Jonas S Heitmann

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Respiratory Syndrome Coronavirus

Immune Response

Stem Cell Transplantation

Top Venues

Nature communications

Cancer immunology, immunotherapy : CII

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Annika Nelde, Heiko Schuster, Jonas S Heitmann, Jens Bauer, Yacine Maringer, Melissa Zwick, Jens-Peter Volkmer, James Y Chen, Anna M Paczulla Stanger, Ariane Lehmann, Bismark Appiah, Melanie Märklin, Elke Rücker-Braun, Helmut R Salih, Malte Roerden, Sarah M Schroeder, Max-Felix Häring, Andreas Schlosser, Johannes Schetelig, Marc Schmitz, Melanie Börries, Natalie Stickel, Claudia Lengerke, Ravindra Majeti, Irving L Weissman, Hans-Georg Rammensee, Juliane Sarah Walz
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells. Blood cancer discovery (2023)
Jonas S Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne M Rittig, Christian M Tegeler, Yacine Maringer, Simon U Jaeger, Monika Denk, Marion Richter, Melek T Oezbek, Karl-Heinz Wiesmüller, Jens Bauer, Jonas Rieth, Marcel Wacker, Sarah M Schroeder, Naomi Hoenisch Gravel, Jonas Scheid, Melanie Märklin, Annika Henrich, Boris Klimovich, Kim L Clar, Martina Lutz, Samuel Holzmayer, Sebastian Hörber, Andreas Peter, Christoph Meisner, Imma Fischer, Markus W Löffler, Caroline Anna Peuker, Stefan Habringer, Thorsten O Goetze, Elke Jäger, Hans-Georg Rammensee, Helmut R Salih, Juliane Sarah Walz
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency. Nature communications 14 (1) (2023)
Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, Lena Mühlenbruch, Sarah M Schroeder, Marian C Neidert, Jonas Scheid, Steffen Lemke, Marissa L Dubbelaar, Marcel Wacker, Anna Dengler, Reinhild Klein, Paul-Stefan Mauz, Hubert Löwenheim, Mathias Hauri-Hohl, Roland Martin, Jörg Hennenlotter, Arnulf Stenzl, Jonas S Heitmann, Helmut R Salih, Hans-Georg Rammensee, Juliane Sarah Walz
TOF IMS mass spectrometry-based immunopeptidomics refines tumor antigen identification. Nature communications 14 (1) (2023)
Joseph Kauer, Melanie Märklin, Martin Pflügler, Sebastian Hörner, Clemens Hinterleitner, Claudia Tandler, Gundram Jung, Helmut R Salih, Jonas S Heitmann
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro. Journal of cancer research and clinical oncology 148 (10) (2022)
Fabian Brunk, Andreas Moritz, Annika Nelde, Tatjana Bilich, Nicolas Casadei, Sabine A K Fraschka, Jonas S Heitmann, Sebastian Hörber, Andreas Peter, Hans-Georg Rammensee, Harpreet Singh, Juliane Sarah Walz, Dominik Maurer, Claudia Wagner
SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function. European journal of immunology 51 (11) (2021)
Tatjana Bilich, Annika Nelde, Jonas S Heitmann, Yacine Maringer, Malte Roerden, Jens Bauer, Jonas Rieth, Marcel Wacker, Andreas Peter, Sebastian Hörber, David Rachfalski, Melanie Märklin, Stefan Stevanovic, Hans-Georg Rammensee, Helmut R Salih, Juliane Sarah Walz
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Science translational medicine 13 (590) (2021)
Yanjun Zhou, Jonas S Heitmann, Kim L Clar, Korbinian N Kropp, Clemens Hinterleitner, Tobias Engler, André Koch, Andreas D Hartkopf, Lars Zender, Helmut R Salih, Stefanie Maurer, Clemens Hinterleitner
Platelet-expressed immune checkpoint regulator GITRL in breast cancer. Cancer immunology, immunotherapy : CII 70 (9) (2021)
Jonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, Lukas Osburg, Helmut R Salih, Joseph Kauer, Melanie Märklin
Fc gamma receptor expression serves as prognostic and diagnostic factor in AML. Leukemia & lymphoma 61 (10) (2020)
Malte Roerden, Annika Nelde, Jonas S Heitmann, Reinhild Klein, Hans-Georg Rammensee, Wolfgang A Bethge, Juliane S Walz
HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation. Cancers 12 (7) (2020)
Jonas S Heitmann, Juliane S Walz, Martin Pflügler, Joseph Kauer, Richard F Schlenk, Gundram Jung, Helmut R Salih
Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma. BMJ open 10 (10) (2020)
Jonas S Heitmann, Melanie Märklin, Felicia M Truckenmüller, Clemens Hinterleitner, Daniela Dörfel, Michael Haap, Hans-Georg Kopp, Stefan Wirths, Martin R Müller
A novel flow cytometry-based assay to measure compromised B cell receptor signaling as a prognostic factor in chronic lymphocytic leukemia. Journal of leukocyte biology 108 (6) (2020)